-+ 0.00%
-+ 0.00%
-+ 0.00%

TATA Health (01255) expects losses attributable to shareholders for the interim period to not exceed HK$1.5 million

Zhitongcaijing·08/28/2026 13:33:23
Listen to the news

Zhitong Finance App News, TATA Health (01255) issued an announcement. The board of directors hereby clarifies that after reviewing the Group's latest unaudited comprehensive financial statements for the six months ended June 30, 2026 and other information currently available, the company discovered minor clerical errors in the profit warning notice. It is expected that the Group's loss attributable to company owners during the reporting period will be reduced from about HK$1.399 million to no more than HK$1.5 million.